Recruiting The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor NCT06863844 Conditions Urothelial Neoplasm Locations IRCCS Azienda Ospedaliero Universitaria Bologna — Bologna, Italy View Trial Details
Recruiting Safely Reduce Cystoscopic Evaluations for Hematuria Patients NCT06026189 Conditions Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +20 more Locations SeARCH-trial Pijpers — Rotterdam, Netherlands View Trial Details
Not Yet Recruiting Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate NCT03698721 Conditions Bladder Exstrophy, Bladder, Neurogenic, Congenital Abnormalities, +22 more Locations Not specified View Trial Details
Completed A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma NCT04200963 Conditions Advanced Cancer, Advanced Solid Tumor, Bladder Cancer, +35 more Locations Banner Health- MD Anderson Cancer Center — Gilbert, Arizona, United States Florida Cancer Specialists - Sarasota — Sarasota, Florida, United States Rush University Medical Center — Chicago, Illinois, United States Johns Hopkins Kimmel Cancer Center — Baltimore, Maryland, United States View more locations Show fewer locations Loading locations... View Trial Details
